You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Head and neck carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous-cell Carcinoma

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
    • (no location specified)
    Nov 5, 2023

    Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Carrilizumab, bevacizumab,capecitabine
    • (no location specified)
    Jul 20, 2023

    Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
      • Hangzhou, Zhejiang, China
        Second Affiliated Hospital, School of Medicine, Zhejiang Univers
      Aug 22, 2023

      Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

      Not yet recruiting
      • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
      • Guangzhou, Guangdong, China
        Sun Yat-sen University
      Oct 24, 2023

      Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +3 more
      • Guangzhou, Guangdong, China
      • +4 more
      Nov 16, 2023

      Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • PET/CT
      • Neck dissection
      • (no location specified)
      Jan 31, 2023

      Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

      Not yet recruiting
      • Locally Advanced Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Mar 20, 2023

      Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial (Tislelizumab, BGB-A425, LBL-007)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Head and Neck Cancer
      • (no location specified)
      Jun 9, 2023

      Squamous Cell Carcinoma of Head and Neck Trial in Toronto (fMRI, Oral Pimonidazole)

      Not yet recruiting
      • Squamous Cell Carcinoma of Head and Neck
      • fMRI
      • Oral Pimonidazole
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Center
      Oct 9, 2023

      Head and Neck Squamous Cell Carcinoma Trial (HS-20093)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Aug 17, 2023

      Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

      Not yet recruiting
      • Recurrent Head and Neck Cancer
      • +5 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jul 30, 2023

      Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial (Ficlatuzumab,

      Not yet recruiting
      • Metastatic Head-and-neck Squamous-cell Carcinoma
      • Recurrent Head and Neck Squamous Cell Carcinoma
      • Ficlatuzumab
      • +2 more
      • (no location specified)
      Sep 26, 2023

      Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Locally Advanced Operable
      • Guangzhou, Guangdong, China
      • +1 more
      Sep 4, 2023

      Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Nab paclitaxel
      • +2 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital
      Aug 24, 2023

      Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • Head and Neck Squamous Cell Carcinoma
      • Chengdu, Sichuan, China
        West China Hospital, Sichuan University
      Oct 25, 2023

      Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial (ALE.C04, Pembrolizumab)

      Not yet recruiting
      • Head and Neck Cancer
      • Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Sep 19, 2023

      Prognostic Immune Biomarkers in HNSCC

      Completed
      • Head and Neck Cancer
      • Squamous Cell Carcinoma
      • Tumour immunoprofile evaluation
      • Ostrava, Moravian-Silesian Region, Czechia
        University Hospital Ostrava
      Jul 3, 2023

      Needs and Preferences of Patients With Head-neck Cutaneous SCC

      Active, not recruiting
      • Cutaneous Squamous Cell Carcinoma
      • +10 more
      • Regular care with additional administration of a semi-structured interview
      • Maastricht, Netherlands
        Maastricht University Medical Center+
      Sep 13, 2023

      Squamous Cell Carcinoma of the Head and Neck (SCCHN), Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Head

      Recruiting
      • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
      • +4 more
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jan 19, 2023

      Head and Neck Squamous Cell Carcinoma Trial (Zanzalintinib, Zanzalintinib-matched Placebo, Pembrolizumab)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Oct 9, 2023

      Head Neck Cancer, Head and Neck Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Chicago (Xevinapant, Carboplatin,

      Not yet recruiting
      • Head and Neck Cancer
      • +2 more
      • Chicago, Illinois
        University of Chicago Medicine Comprehensive Cancer Center
      Oct 25, 2023

      Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)

      Not yet recruiting
      • Head Neck
      • Squamous Cell Carcinoma of Head and Neck
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 14, 2023

      Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Chengdu (Netopitam Palonosetron capsules and dexamethasone)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma (HNSCC)
      • Netopitam Palonosetron capsules and dexamethasone
      • Chengdu, Sichuan, China
        Sichuan Cancer Hospital and Research Institute
      Oct 22, 2023

      Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Penpulimab injection, cisplatin, albumin-paclitaxel)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Penpulimab injection
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University
      Oct 7, 2023

      Following Salvage Surgery for RESidual or reCurrent sqUamous

      Not yet recruiting
      • Head and Neck Cancer
      • Molecular Analyses
      • (no location specified)
      Mar 28, 2023